Fit-for-purpose wearable sensors, guaranteed transparency and inspection-ready data provenance at every step; from patient body to data handoff.
Patient-centric designs, with the smallest wearable sensors and tailored adhesives, result in industry-leading adherence.
Use of FDA and CE Cleared, clinically validated medical wearables ensure a high level of data integrity for regulatory compliance.
Discover how to move beyond self-reported data and finally capture real-time, clinical-grade insights from remote participants—consistently, automatically, and at scale.
Using a rechargeable wearable ECG monitor, this longitudinal study of up to 3,000 subjects aims to detect biomarkers of early atrial transformation in atrial fibrillation.
This study investigates whether emotion regulation is impaired in individuals with sleep bruxism, while controlling for affective and sleep disturbances.
The capabilities of the Vivalink ECG sensor will enable us to capture a larger continuous dataset in order to help achieve our goals.
Jeffrey Olgin, MD
UCSFWe're detecting arrhythmias within 14 days following discharge that otherwise wouldn't have been caught until three months postoperatively.
Jakob Wollborn, MD, MPH
Brigham and Women's HospitalVivalink’s wearable ECG devices help to identify concerning cardiac patterns associated with seizures that often go unnoticed.
Fawad Khan, MD
Ochsner HealthVivalink's medical-grade sensors and data services will help us find accurate endpoints during the trial.
Theodore Abraham, MD
UCSFThe integration of [Vivalink’s] innovative RPM technology with [Clario's] global clinical trial infrastructure will open new paradigms for trial data collection and analysis.
Thomas Fuerst, Ph.D.
ClarioMedical wearables are making it possible to explore new, potentially meaningful outcomes in clinical studies without adding much additional burden to patients or their clinicians.
Rob Roscigno, PhD
Gossamer Bio